MarginsXMarginsX
Home › Markets › Health Care › IRIX

IRIDEX Corporation (IRIX)

IRIX trades on Nasdaq in Health Care, Biotechnology: Electromedical & Electrotherapeutic Apparatus. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$0.6878
-0.32% on the day
Market cap
$12.1M
Nano cap
Revenue · 2025
$52.7M
+8.2% on 2024
Net income · 2025
-$4.4M
-8.4% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2026-01-03, https://www.sec.gov/Archives/edgar/data/1006045/000119312526140194/0001193125-26-140194-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2026-01-03.

Profile

FieldValue
TickerIRIX on Nasdaq
SectorHealth Care
IndustryBiotechnology: Electromedical & Electrotherapeutic Apparatus
CountryUnited States
IPO year1996
SEC CIK0001006045
SEC industry codeElectromedical & Electrotherapeutic Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$52.7M
Net income-$4.4M
Operating income-$2.6M
Net margin-8.4%
Operating margin-4.9%
Revenue growth+8.2%
Cash$6.0M
Total assets$29.2M
P/E (computed)Net income was not positive
P/S (computed)0.2×

Warning signs

Cash runway
32.5 months
$4.7M cash at July 4, 2026
Share count, 1 year
+3.4%
2025-08-07 to 2026-08-13 · +8.2% over 3 years
Going-concern doubt
No
10-Q filed August 18, 2026
Insider net buying, 12 months
$151K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-08-18
Cash and burn$4.7M cash; operating cash flow -$433K a quarter.Report 2026-07-04
Shares outstanding17,564,912 (2026-08-13); 16,992,253 a year earlier; 16,229,103 three years earlier.Cover page 2026-08-13
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 months1 (8-K item 3.01)8-K 2026-09-02
AuditorBPM LLP, San Jose, California, United StatesPCAOB Form AP 2026-04-03
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $151K, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-07-04
$12.6M-$1.3M$174K$4.7MNo debt tags$51.6M10-Q 2026-08-18
Q1 2026
2026-04-04
$11.8M-$524K-$1.3M$4.6MNo debt tags$52.6M10-Q 2026-05-19
Q4 2025
2026-01-03
$14.7M-$184K$589K$6.0M$0$52.7M10-K 2026-04-02
Q3 2025
2025-09-27
$12.5M-$1.6M-$1.2M$5.6M$0$50.6M10-Q 2025-11-12
Q2 2025
2025-06-28
$13.6M-$994K-$397K$6.8M$0$49.7M10-Q 2026-08-18
Q1 2025
2025-03-29
$11.9M-$1.7M-$1.1M$7.2M$0$48.8M10-Q 2026-05-19
Q4 2024
2024-12-28
$12.7M-$834K-$1.2M$2.4M$2.7M$48.7M10-K 2026-04-02
Q3 2024
2024-09-28
$11.6M-$1.9M-$3.1M$3.9M$2.7M$48.4M10-Q 2025-11-12

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B32024-09-25
Latest annual report10-K2026-04-02
Latest quarterly / interim10-Q2026-08-18
Latest current report8-K2026-09-02
Latest proxy
DEFINITIVE ADDITIONAL MATERIALS
DEFA14A2026-04-24

Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+4.5%
1 month-18.8%
3 months-15.9%
Year to date-39.5%
1 year-22.5%
From 52-week high-55.8%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Electromedical & Electrotherapeutic Apparatus

TickerCompanyPriceDayMarket cap
ITOCiTonic Holdings Ltd$1.88-5.05%$13.8M
NDRAENDRA Life Sciences Inc.$4.42-1.78%$6.6M
QTIQT Imaging Holdings Inc.$1.80-4.26%$26.4M
ECORelectroCore Inc.$4.84-7.81%$44.7M
POCIPrecision Optics Corporation Inc.$4.97-4.97%$54.6M
NUWENuwellis Inc.$4.48-8.57%$2.4M
OMOutset Medical Inc.$3.39-9.12%$64.0M
HYPRHyperfine Inc.$0.6101-3.05%$64.8M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier